Clinical Trials/ACTRN12619001518156

ACTRN12619001518156

Not yet recruiting

未知

itric Oxide on ExtraCorporeal Membrane Oxygenation – a randomised Trial in neonates and children (NECTAR trial).

The University of Queensland0 sites50 target enrollmentNovember 4, 2019

ConditionsCardiovascular failure requiring Extracorporeal Membrane Oxygenation Respiratory failure requiring Extracorporeal Membrane Oxygenation Respiratory - Other respiratory disorders / diseases Cardiovascular - Other cardiovascular diseases

Overview

Phase: 未知
Intervention: Not specified
Conditions: Cardiovascular failure requiring Extracorporeal Membrane Oxygenation
Sponsor: The University of Queensland
Enrollment: 50
Status: Not yet recruiting
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

November 4, 2019

End Date

TBD

Last Updated

6 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

The University of Queensland

Eligibility Criteria

Inclusion Criteria

•1\. All neonates and children \< 18 years requiring ECMO for respiratory or cardiovascular dysfunction including extracorporeal cardiopulmonary resuscitation (eCPR)
•2\. Ability to obtain prospective consent or consent to continue from parents/guardian.

Exclusion Criteria

•1\. Patients retrieved to PICU on ECMO who did not undergo randomisation during cannulation
•2\. Pre\-existing methaemoglobinemia (MetHb\>3%)
•3\. Anticipated inability to obtain parental consent (prospective consent or consent to continue)
•4\. Patients managed on ventricular assist device (VAD) only without an oxygenator present in the ECMO circuit

Outcomes

Primary Outcomes

Not specified

Similar Trials

nderstanding Extracorporal Membrane Oxygenation Induced Coaguloapathy – A Prospective Cohort Study in the Intensive Care Unit (EXTRICATE)In VV-ECMO patients with severe ARDSin VA-ECMO patients with cardiac arrest during ongoing resuscitation.

DRKS00033769niversität Witten/Herdecke & Klinik Köln Merheim50

Not yet recruiting

Pilot study investigating how Extracorporeal Membrane Oxygenation (ECMO) affects the major breathing muscles.Diaphragm atrophyECMOMusculoskeletal - Other muscular and skeletal disordersRespiratory - Other respiratory disorders / diseases

ACTRN12616000944437Trent Donnelly20

Effect of Extracorporeal membrane oxygenation flow on Venous Congestion and abdominal Organ PerfusioJ80.0

DRKS00032063niversitätsmedizin Göttingen70

ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory DiseaseCOVID-19

JPRN-UMIN000039686Critical Care Research Group The Prince Charles Hospital20,000

Extracorporeal membrane oxygenation in patients with coronavirus disease 2019PCR-proven COVID-19, resulting in respiratory or cardiorespiratory insufficiency, refractory to conventional therapies.

NL-OMON27273/A200